Previous close | 99.08 |
Open | 99.92 |
Bid | 101.28 x 3100 |
Ask | 101.29 x 1200 |
Day's range | 99.73 - 101.41 |
52-week range | 93.25 - 124.36 |
Volume | |
Avg. volume | 5,172,203 |
Market cap | 176.554B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | 31.72 |
EPS (TTM) | 3.19 |
Earnings date | 18 Apr 2023 - 24 Apr 2023 |
Forward dividend & yield | 2.04 (1.85%) |
Ex-dividend date | 12 Jan 2023 |
1y target est | 123.50 |
Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.
Abbott (ABT) closed at $98.46 in the latest trading session, marking a +0.42% move from the prior day.
Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.